Search Results 1841-1850 of 21519 for platelets

1. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Platelet count ≥ 100,000/mm^3;; Hemoglobin ≥ 9.0 g/dL without transfusion or EPO dependency (≤7 days prior to assessment);; Prothrombin Time (PT) ≤ 1.5 x ...

2. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

   - Platelets ?75,000/mm³ - Creatinine clearance ≥ 40 mL/min, calculated with the use of 24-hour creatinine clearance or by Cockcroft-Gault formula - Total ...

3. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

   - Platelets ≥ 50 × 109/L not requiring transfusion support or growth factors within 7 days of screening. - AST and ALT ≤ 3.0 x upper limit of normal (ULN)

4. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

   Platelets ≥ 50 x 10^9/L;; Hemoglobin ≥ 8 g/dL (transfusions are permitted to achieve baseline hemoglobin level);. ALT/AST (alanine aminotransferase (ALT) ...

5. A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   Platelets < 50000 µL. Severe systolic dysfunction defined as ejection fraction < 14%. Serum sodium levels < 130 mmol/L or >145 mmol/L. Taking any other ...

6. A Study to Evaluate Chemotherapy and Radiation Therapy With or Without Surgery to Treat Patients With Head and Neck Cancer - Mayo Clinic

   platelet count of > 100,000 cells/mm^3;; adequate hepatic function with bilirubin < 1.5 mg/dl;; AST or ALT < 2 x the upper limit of normal;; serum creatinine ...

7. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

   Disease or medication-related disorder of coagulation (i.e., elevated PTT > 13.8 seconds, INR > 1.2, or low platelet count < 150 x 10^9/L). Patients on ...

8. Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer - Mayo Clinic

   platelets ≥100,000/mcL; total bilirubin <1.5 X upper normal institutional limit; AST(SGOT)/ALT(SGPT) ≤2.5 X institutional upper limit of normal; creatinine ...

9. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   Platelet count ≥100,000/mm^3;; Hemoglobin ≥8.0g/dL;; Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; Total or direct bilirubin < 2 x ...

10. Hematology - Doctors - Mayo Clinic

    Godby, M.D.. Hematologist. Rochester, MN. Areas of focus: Bone marrow biopsy and aspiration, Platelet transfusion, Blood transfusion, Immunosuppressive drug ...